首页|基于FAK/Src/ERK通路探讨西黄丸对前列腺癌血管生成、侵袭和转移的影响

基于FAK/Src/ERK通路探讨西黄丸对前列腺癌血管生成、侵袭和转移的影响

扫码查看
基于局部黏着斑激酶(FAK)/类固醇受体共激活因子(Src)/细胞外调节蛋白激酶(ERK)通路,探讨西黄丸对前列腺癌血管生成、侵袭、转移的影响.利用液相色谱串联质谱技术对西黄丸的活性成分进行分析与鉴定.利用R语言和Perl语言程序等生物信息学技术分析前列腺癌相关靶点与西黄丸潜在靶点之间的相互作用.利用PC3细胞制备裸小鼠前列腺癌皮下移植瘤模型,验证西黄丸的疗效和分子机制.体外细胞实验分别采用细胞增殖毒性检测试剂盒(CCK-8)法、Transwell、划痕实验、实时定量逆转录PCR和蛋白免疫印记实验检测西黄丸萃取液对前列腺癌细胞增殖、侵袭和迁移以及FAK/Src/ERK通路相关靶点的影响.液相色谱串联质谱技术鉴定出没食子酸、龙胆酸、青蒿烯、柯里拉京、苯基丁酮-葡萄糖苷、苏木酸、arecoic acid B等在内的西黄丸99种活性成分.基于西黄丸活性成分的网络药理学分析显示,FAK/Src/ERK信号通路为其抗前列腺癌的关键途径.体内外实验结果验证,西黄丸能够抑制PC3、LNCaP细胞的增殖、侵袭与迁移,并抑制PC3皮下移植瘤的生长,降低FAK/Src/ERK信号通路相关蛋白表达水平.综上,通过调节FAK/Src/ERK通路抑制血管生成、侵袭、迁移是西黄丸抗前列腺癌机制之一.
Effects of Xihuang Pills on angiogenesis,invasion,and metastasis of prostate cancer based on FAK/Src/ERK pathway
Based on the focal adhesion kinase (FAK)/steroid receptor coactivator (Src)/extracellular regulated protein kinase (ERK) pathway,this study explored the effects of Xihuang Pills on angiogenesis,invasion,and metastasis in prostate cancer.Liquid chromatography-tandem mass spectrometry (LC-MS/MS) was used to analyze and identify the active ingredients of Xihuang Pills.Bioinformatics techniques,including R language and Perl programs,were employed to analyze the interactions between prostate cancer-related targets and the potential targets of Xihuang Pills.A subcutaneous transplantation tumor model of prostate cancer was established in nude mice using PC3 cells to verify the efficacy and molecular mechanisms of Xihuang Pills.In vitro cellular experiments,including cell proliferation assays (CCK-8),Transwell assays,scratch assays,real-time quantitative reverse transcription PCR,and Western blot,were used to detect the effects of Xihuang Pills on the proliferation,invasion,and migration of prostate cancer cells,as well as on FAK/Src/ERK pathway-related targets.LC-MS/MS identified 99 active ingredients in Xihuang Pills,including gallic acid,gentisic acid,artemisinin,corilagin,phenylbutazone-glucoside,thujic acid,and arecoic acid B.Network pharmacological analysis of the active ingredients in Xihuang Pills revealed that the FAK/Src/ERK signaling pathway was a key pathway in its anti-prostate cancer effects.In vivo and in vitro experiments confirmed that Xihuang Pills significantly inhibited the proliferation,invasion,and migration of PC3 and LNCaP cells,suppressed the growth of PC3 subcutaneous tumors,and reduced the protein expression levels related to the FAK/Src/ERK signaling pathway.In conclusion,the inhibition of angiogenesis,invasion,and metastasis by regulating the FAK/Src/ERK pathway is one of the mechanisms by which Xihuang Pills exert anti-prostate cancer effects.

Xihuang Pillsprostate cancerFAK/Src/ERK signalling pathwayangiogenesis

龙衍、罗新筠、邹博、戴新军、符方智、王彪、吴丽通、吴泳蓉、周青、田雪飞

展开 >

湖南中医药大学第一附属医院男科,湖南长沙 410007

湖南中医药大学中医方证与转化湖南省重点实验室,湖南长沙 410208

湖南中医药大学中医药防治肿瘤机理重点研究室,湖南 长沙 410208

湖南中医药大学附属浏阳市中医医院,湖南长沙 410300

湖南中医药大学湖南省高校中医肿瘤重点实验室,湖南长沙 410208

湖南中医药大学中医学院,湖南长沙 410208

湖南中医药大学中西医结合学院,湖南长沙 410208

展开 >

西黄丸 前列腺癌 FAK/Src/ERK信号通路 血管生成

2024

中国中药杂志
中国药学会

中国中药杂志

CSTPCD北大核心
影响因子:1.718
ISSN:1001-5302
年,卷(期):2024.49(23)